1. Home
  2. PNFP vs NUVL Comparison

PNFP vs NUVL Comparison

Compare PNFP & NUVL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pinnacle Financial Partners Inc.

PNFP

Pinnacle Financial Partners Inc.

N/A

Current Price

$85.62

Market Cap

7.8B

Sector

Finance

ML Signal

N/A

Logo Nuvalent Inc.

NUVL

Nuvalent Inc.

N/A

Current Price

$101.08

Market Cap

8.1B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
PNFP
NUVL
Founded
2000
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.8B
8.1B
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
PNFP
NUVL
Price
$85.62
$101.08
Analyst Decision
Buy
Strong Buy
Analyst Count
16
15
Target Price
$112.20
$135.33
AVG Volume (30 Days)
1.2M
435.7K
Earning Date
01-01-0001
05-27-2026
Dividend Yield
2.26%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$163.66
N/A
Revenue Next Year
$7.77
$1,064.25
P/E Ratio
$12.24
N/A
Revenue Growth
N/A
N/A
52 Week Low
$81.57
$55.54
52 Week High
$120.39
$113.02

Technical Indicators

Market Signals
Indicator
PNFP
NUVL
Relative Strength Index (RSI) 33.98 49.88
Support Level $83.62 $98.65
Resistance Level $90.97 $107.13
Average True Range (ATR) 3.37 3.97
MACD -0.91 -0.15
Stochastic Oscillator 16.66 50.05

Price Performance

Historical Comparison
PNFP
NUVL

About PNFP Pinnacle Financial Partners Inc.

Pinnacle Financial Partners Inc is a financial holding company. The company operates through its wholly-owned subsidiary, Pinnacle Bank. The bank provides a full range of lending products, including commercial, real estate, and consumer loans to individuals and small to medium-sized businesses. It operates as a community bank mainly in the urban markets of Nashville, Knoxville, Memphis, and Chattanooga, Tennessee, as well as surrounding counties. It relies heavily on mergers and acquisitions. A majority of its loan portfolio is in commercial loans, mainly real estate, as well as industrial loans. The bank generates a majority of its net revenue through net interest income.

About NUVL Nuvalent Inc.

Nuvalent Inc is a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for patients with cancer. All of its operations are in the United States. The company is engaged in developing small molecules that are designed to overcome the limitations of existing therapies for clinically validated kinase targets. The product candidates of the company include NVL-520, which is being developed for patients with ROS1-positive non-small cell lung cancer (NSCLC), NVL-655, which is being developed for patients with anaplastic lymphoma kinase (ALK)-positive NSCLC, NVL-330, is a brain-penetrant human epidermal growth factor receptor 2 (HER2)-selective inhibitor designed to address the combined medical need of treating tumors driven by HER2ex20.

Share on Social Networks: